VG
Schedule 13D filing
venBio Global Strategic Fund, L.P. disclosed a 10% stake in ALXO
venBio Global Strategic Fund, L.P. reported owning 10% of Alx Oncology Holdings Inc (ALXO) (12,927,442 shares) in a Schedule 13D filed Oct 17, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 17, 2026
- Source
- Schedule 13D
More ALXO insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.